Pfizer CFO to step down; Denali sells a regulatory fast-pass
admin The dynamic biopharmaceutical sector witnessed a series of significant developments this week, reflecting ongoing shifts...
drug development
Legend Biotech’s In Vivo CAR-T Therapy LB2501 Achieves Full Remissions in Initial Lymphoma Trial, Signaling a Potential Paradigm Shift in Cell Therapy
Shanghai, China – June 3, 2026 – Legend Biotech, a prominent biopharmaceutical company, has announced...
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
The pharmaceutical landscape witnessed a dynamic week marked by significant market fluctuations, pivotal regulatory advancements,...
European Regulators Endorse Sanofi’s Tolebrutinib for Multiple Sclerosis, Diverging from FDA Stance
Sanofi’s experimental multiple sclerosis treatment, tolebrutinib, has received a crucial positive recommendation from European drug...
Roche Launches New Global Phase 3 Trial for Elevidys, Revitalizing Bid for European Approval of Duchenne Gene Therapy
The Swiss pharmaceutical giant Roche has announced the initiation of a new global Phase 3...
Eli Lilly’s Foundayo Achieves Cardiovascular Safety Milestone, Paving Way for Diabetes Approval Amidst Broader GLP-1 Market Expansion
Eli Lilly and Company’s oral obesity drug, Foundayo, has successfully met its primary objective in...
Trump Nominates Erica Schwartz to Lead Tumultuous CDC Amidst Public Health Policy Overhaul
President Donald Trump on Thursday announced his nomination of Erica Schwartz, a prominent public health...
Big Pharma CEOs Defy Market Trends with Soaring Multi-Million Dollar Compensation Packages in 2025 Amidst Strategic Triumphs and Public Scrutiny
While chief executives at S&P 500 companies generally experienced a median salary increase of approximately...
UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
Belgian biopharmaceutical giant UCB announced Friday a definitive agreement to acquire Neurona Therapeutics, a privately...
Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
The biopharmaceutical landscape witnessed a flurry of significant developments this past week, ranging from the...
